Inmune Bio, Inc. (INMB) has 39 open-market insider trades by 6 insiders since 2019. The most active filer is Raymond Joseph Tesi, CEO & President.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Linda F. Powers | 10% Owner | — | 3 | $2.6M | 2020-01-27 |
| Raymond Joseph Tesi | CEOPres | — | 12 | $2.0M | 2024-09-12 |
| Timothy J. Schroeder | Dir | — | 5 | $1.6M | 2023-07-12 |
| David J. Moss | CEO | — | 10 | $1.1M | 2026-07-02 |
| Mark William Lowdell | CSO | — | 3 | $743K | 2026-07-02 |
| Scott Juda | Dir | — | 6 | $455K | 2026-07-02 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| David J. Moss | CFO | Buy | $53K | 2024-09-30 |
| Raymond Joseph Tesi | CEO & President | Buy | $196K | 2024-09-12 |
| David J. Moss | CFO & 10% | Buy | $49K | 2024-09-12 |
| Scott Juda | Director | Buy | $36K | 2024-06-25 |
| Raymond Joseph Tesi | CEO & President | Buy | $150K | 2024-04-19 |
| Mark William Lowdell | CSO | Buy | $120K | 2024-04-19 |
Companies that share insiders with INMB, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Scott Juda | Director | Buy | $246K | 2024-04-19 |
| Scott Juda | Director | Buy | $49K | 2023-11-10 |
| Timothy J. Schroeder | Director | Sell | $110K | 2023-07-12 |
| David J. Moss | CFO & Secretary +1 | Buy | $16K | 2023-03-17 |
| David J. Moss | CFO & Secretary +1 | Buy | $69K | 2022-05-26 |
| Raymond Joseph Tesi | President & 10% | Buy | $40K | 2022-05-26 |
| Scott Juda | Director | Buy | $34K | 2021-11-17 |
| Raymond Joseph Tesi | CEO & President | Sell | $73K | 2021-11-03 |
| Mark William Lowdell | Chief Scientific Officer & 10% | Sell | $14K | 2021-11-03 |